课题基金 / 基金详情

NOVEL GLOBIN GENE MODULATORS

NOVEL GLOBIN GENE MODULATORS
新型球蛋白基因调节剂
批准号:
2906080
负责人:
SUSAN Park PERRINE
金额:
$33.92万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-06-01 至 2002-05-31

项目摘要

项目成果

SUSAN Park PERRINE的其他基金

相似基金

相关文献

中文摘要
翻译
描述:本研究计划的总体目标是测试
英文摘要
DESCRIPTION: The overall goal of this research proposal is to test the hypothesis that stable gamma-globin inducers which do not inhibit erythroid cell proliferation and may be given frequently, will result in superior long-term hemoglobin F inducibility in the absence of hematologic suppression in vivo. Specific aims are to: 1) identify oral fetal globin gene inducers with favorable in vivo kinetics; 2) determine the effects of long term administration of oral hemoglobin F inducers in non-human primates; and 3) determine whether synergy results with their combined use with other compounds known to stimulate HbF production. The primary screen for gamma-globin inducibility will be performed using K562 cells alone and those stably transfected with promoter/reporter constructs, erythroid progenitor cultures and a responsive multi-lineage cell line. Hemoglobin F inducers which stimulate or do not inhibit erythropoiesis in vitro will be studied in baboons to determine oral pharmacokinetics, safety and to develop effective long-term regimens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Topical Therapeutic to Promote Healing of Chronic Wounds
  • 批准号:
    8454815
  • 项目类别:
  • 资助金额:
    $21.93万
  • 财政年份:
    2013
  • 负责人:
    SUSAN Park PERRINE
  • 依托单位:
Next Generation Therapeutics for Hemoglobinopathies
  • 批准号:
    8250888
  • 项目类别:
  • 资助金额:
    $49.13万
  • 财政年份:
    2012
  • 负责人:
    SUSAN Park PERRINE
  • 依托单位:
Development of a clinical hemoglobin modulator
  • 批准号:
    8782071
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2011
  • 负责人:
    SUSAN Park PERRINE
  • 依托单位:
Virus-targeted therapeutic for EBV-Associated Malignancies
  • 批准号:
    9312763
  • 项目类别:
  • 资助金额:
    $51.96万
  • 财政年份:
    2011
  • 负责人:
    SUSAN Park PERRINE
  • 依托单位:
海外基金